News & Updates

5α-reductase inhibitors help reduce SARS-CoV-2 infection risk in men

10 Jan 2022 by

Use of 5α-reductase inhibitors (5ARIs) appears to lower the risk of community-acquired infection with SARS-CoV-2 in men without prostate cancer, according to a study, noting that treatment with this drug class can help ease the burden of COVID-19.

5α-reductase inhibitors help reduce SARS-CoV-2 infection risk in men

10 Jan 2022

Breakthrough COVID-19 infections severe in blood cancer patients

10 Jan 2022 by

While getting vaxxed remains the best protection against severe COVID-19, severe breakthrough infections are still possible, particularly in patients with haematological malignancies, a registry-based study has shown.

Breakthrough COVID-19 infections severe in blood cancer patients

10 Jan 2022

OAC treatment rates in AF patients improve but still far from ideal

10 Jan 2022

The treatment scope of oral anticoagulants (OACs) remains poor despite increasing treatment rates among high-risk atrial fibrillation (AF) patients, which is primarily credited to the expanding direct oral anticoagulant (DOAC) use, reports an Israel study.

OAC treatment rates in AF patients improve but still far from ideal

10 Jan 2022

Wearables predict survival in end-stage cancer patients on palliative care

10 Jan 2022 by

Wristband actigraphy devices, through the help of deep-learning prediction models, can predict survival outcomes in end-stage cancer patients on palliative care, according to a recent study.

Wearables predict survival in end-stage cancer patients on palliative care

10 Jan 2022

Lower rates of digestive cancer treatment in older patients due to pandemic lockdowns

10 Jan 2022

The coronavirus disease 2019 (COVID-19) pandemic has led to a sharp decline in treatment for older patients with newly diagnosed cancers of the digestive system, a recent study has found.

Lower rates of digestive cancer treatment in older patients due to pandemic lockdowns

10 Jan 2022

Short interspinous diameter makes rectal surgery more difficult

10 Jan 2022

Interspinous diameter seems to be an important factor affecting the difficulty of laparoscopic surgery in patients with mid-low rectal cancer, suggesting that magnetic resonance imaging (MRI) pelvimetry is helpful in gauging the technical difficulty of rectal surgery, a recent study has found.

Short interspinous diameter makes rectal surgery more difficult

10 Jan 2022

RAS WT mCRC: Maintenance panitumumab + chemo improves PFS vs chemo alone

10 Jan 2022 by

In patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) who respond to first-line induction therapy with panitumumab plus fluorouracil, folinic acid and oxaliplatin (FOLFOX), maintenance panitumumab plus fluorouracil and folinic acid (FU/FA) significantly improves progression-free survival (PFS) vs FU/FA alone, results of the PANAMA trial have shown.

RAS WT mCRC: Maintenance panitumumab + chemo improves PFS vs chemo alone

10 Jan 2022

Metformin disappoints in early breast cancer

10 Jan 2022 by

Adjuvant treatment with metformin does not improve outcomes in most patients with early breast cancer in a phase III study, suggesting that metformin should not be used as a breast cancer treatment in these patients.